Mayor Issues Statement Regarding Medtronic Closure
October 8, 2021 at 7:24 p.m.
Mayor Issues Statement Regarding Medtronic Closure
By David [email protected]
In his statement, Thallemer said, “Yesterday, I received communication from Medtronic officials confirming the news to close the Warsaw facility by 2024. I initiated a follow-up phone discussion this morning and was told that while they didn’t have an exact number, it would involve approximately 300 employees.
“In 2011, Medtronic employed 659 locally.
“Our community is very proud of the quality and skill of our local workforce. When something like this happens, our first priority is to support those workers and their families in that transition. Given that this will occur over the next few years, hopefully that extra time will allow a smoother, more favorable transition for those dedicated employees.”
Thallemer continued, “The city will assist those employees and their families, working with our local economic development officials (KEDCO) and workforce partners, to provide transition and employment services locally.
“Communication from Medtronic promised severance benefits, redeployment support and outplacement assistance. It further stated ‘ … the decision to close does not reflect on any of them (employees), their dedication or the quality of their work over the years.”
Thallemer said company officials said there would be no immediate displacement but that it would occur over the time period as individual product lines are transitioned to other Medtronic facilities.
Medtronic built its current local facility in 2000.
“While this is not something anyone expected or wanted to occur, we are confident that there is considerable opportunity in our community and we will do everything we can to assist those employees and their families,” Thallemer’s statement concluded.
According to a statement provided to the Times-Union Thursday from a Medtronic spokesperson, “Medtronic operates within a highly competitive global healthcare environment. Throughout the company’s global locations, we consistently evaluate our operations to advance growth, improve operational efficiency and strengthen our position for the future.
“As a result, Medtronic is transitioning manufacturing from the facility in Warsaw, Ind., to other Medtronic manufacturing facilities in its operations network over the next few years. The Warsaw site will continue to manufacture Medtronic products until all transfers are completed. The site is expected to close in 2024.
“We recognize the strong work, dedication and quality of the Warsaw team and will be providing assistance to help impacted employees through these transitions, including possible redeployment opportunities in Medtronic.”
The Warsaw site is at 2500 Silveus Crossing.
According to Medtronic’s website at medtronic.com, Medtronic is among the largest medical device companies in the world. With operations in 150 countries, Medtronic’s products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems and more. The company has over 90,000 employees.
In his statement, Thallemer said, “Yesterday, I received communication from Medtronic officials confirming the news to close the Warsaw facility by 2024. I initiated a follow-up phone discussion this morning and was told that while they didn’t have an exact number, it would involve approximately 300 employees.
“In 2011, Medtronic employed 659 locally.
“Our community is very proud of the quality and skill of our local workforce. When something like this happens, our first priority is to support those workers and their families in that transition. Given that this will occur over the next few years, hopefully that extra time will allow a smoother, more favorable transition for those dedicated employees.”
Thallemer continued, “The city will assist those employees and their families, working with our local economic development officials (KEDCO) and workforce partners, to provide transition and employment services locally.
“Communication from Medtronic promised severance benefits, redeployment support and outplacement assistance. It further stated ‘ … the decision to close does not reflect on any of them (employees), their dedication or the quality of their work over the years.”
Thallemer said company officials said there would be no immediate displacement but that it would occur over the time period as individual product lines are transitioned to other Medtronic facilities.
Medtronic built its current local facility in 2000.
“While this is not something anyone expected or wanted to occur, we are confident that there is considerable opportunity in our community and we will do everything we can to assist those employees and their families,” Thallemer’s statement concluded.
According to a statement provided to the Times-Union Thursday from a Medtronic spokesperson, “Medtronic operates within a highly competitive global healthcare environment. Throughout the company’s global locations, we consistently evaluate our operations to advance growth, improve operational efficiency and strengthen our position for the future.
“As a result, Medtronic is transitioning manufacturing from the facility in Warsaw, Ind., to other Medtronic manufacturing facilities in its operations network over the next few years. The Warsaw site will continue to manufacture Medtronic products until all transfers are completed. The site is expected to close in 2024.
“We recognize the strong work, dedication and quality of the Warsaw team and will be providing assistance to help impacted employees through these transitions, including possible redeployment opportunities in Medtronic.”
The Warsaw site is at 2500 Silveus Crossing.
According to Medtronic’s website at medtronic.com, Medtronic is among the largest medical device companies in the world. With operations in 150 countries, Medtronic’s products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems and more. The company has over 90,000 employees.
Have a news tip? Email [email protected] or Call/Text 360-922-3092